|
|
羅沙司他Z3
|
2599284-48-5
|
|
1,3-Dinitroglycerin
|
硝化甘油溶液EP雜質(zhì)E
|
623-87-0
|
|
Candesartan Cilexetil EP IMpurity G
|
坎地沙坦酯雜質(zhì)G
|
139481-59-7
|
|
(S)-Cetirizine Dihydrochloride
|
鹽酸右西替利嗪
|
163837-48-7
|
|
|
葉酸雜質(zhì)E
|
|
|
Valsartan Isopropyl Ester
|
纈沙坦異丙酯SK-SM3-Q1
|
1245820-09-0
|
|
|
鹽酸普羅帕酮片雜質(zhì)F
|
1329643-40-4
|
|
|
2-磺基色氨酸
|
|
|
Methyl 3-(3,4-dihydroxyphenyl)propanoate
|
3,4-二羥基苯丙酸甲酯
|
3598-22-9
|
|
|
頭孢托侖匹酯7-反式異構(gòu)體
|
878002-86-9
|
|
|
羅沙司他Z1
|
1421312-33-5
|
|
|
3-氯-4-氟苯胺 在喹唑啉環(huán) 4，7 位雙取代
|
2044702-52-3
|
|
|
羅沙司他P-11
|
808118-34-5
|
|
|
3-乙酰胺基鄰苯二甲酸
|
15371-06-9
|
|
3-nitro-4-phenoxybenzoic acid
|
布美他尼2-a
|
202209-14-1
|
|
Fructosazine
|
果糖嗪
|
13185-73-4
|
|
|
噻嗎洛爾EP雜質(zhì)E
|
1026075-53-5
|
|
Mirabegron Impurity 10
|
米拉貝隆雜質(zhì)10
|
|
|
(1R,2S,3S)-Aprepitant
|
阿瑞匹坦RSS雜質(zhì)
|
172822-28-5
|
|
|
4-乙酰氨基鄰苯二甲酸酐
|
22235-04-7
|
|
Candesartan Cilexetil EP Impurity F
|
坎地沙坦酯雜質(zhì)F
|
914613-36-8
|
|
|
帕洛諾司瓊雜質(zhì)D
|
135755-51-0
|
|
|
氨曲南雜質(zhì)F
|
102579-57-7
|
|
Aprepitant Impurity 8 HCl
|
阿瑞匹坦RSS雜質(zhì)鹽酸鹽
|
1333998-27-8
|
|
|
左乙拉西坦RC1
|
102849-49-0
|
|
|
|
2197420-75-8
|
|
3-nitro-4-phenoxy-5-sulfobenzoic acid
|
布美他尼5-a
|
751422-00-1
|
|
|
普萘洛爾雜質(zhì)10
|
34646-56-5
|
|
Candesartan Cilexetil EP Impurity E
|
坎地沙坦酯雜質(zhì)E
|
914613-35-7
|
|
Candesartan Cilexetil EP Impurity D
|
坎地沙坦酯雜質(zhì)D
|
1185256-03-4
|
|
|
鹽酸普羅帕酮片雜質(zhì)D
|
91401-73-9
|
|
Olmesartan Medoxomil EP Impurity D
|
奧美沙坦酯雜質(zhì)D
|
1020157-01-0
|
|
|
艾沙康唑硫酸鹽對照品
|
946075-13-4
|
|
|
雜質(zhì)10
|
1621182-18-0
|
|
Bromocriptine mesylate
|
甲磺酸溴隱亭
|
22260-51-1
|
|
|
羅沙司他SMA-1(
|
2376195-48-9
|
|
Landiolol Impurity 18
|
蘭地洛爾雜質(zhì)18
|
1582797-17-8
|
|
2-(R)-[1-(S)-(3,5-Bis(trifluoroMethyl)phenyl)ethoxy]-3-(S)-fluorophenylMorpholine
|
阿瑞匹坦SRS雜質(zhì)鹽酸鹽
|
170729-79-0
|
|
Trazodone Impurity J
|
鹽酸曲唑酮雜質(zhì)J
|
1263278-79-0
|
|
|
唑吡坦雜質(zhì)A
|
|
|
Loxoprofen Impurity D
|
洛索洛芬鈉雜質(zhì)D
|
1091621-61-2
|
|
1-((2-hydroxyethyl)amino)-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol
|
|
1415561-33-9
|
|
|
頭孢他啶雜質(zhì)A
|
1000980-60-8
|
|
|
羅沙司他Z2
|
421312-35-7
|
|
|
氨芐西林EP雜質(zhì)C
|
49841-96-5
|
|
|
利伐沙班雜質(zhì)C
|
1616563-62-2
|
|
|
|
295357-66-3
|
|
2-Chlorobenzoic acid
|
2-氯苯甲酸
|
118-91-2
|
|
Hydrochlorothiazide EP Impurity C
|
氫氯噻嗪雜質(zhì)C
|
402824-96-8
|
|
|
利伐沙班雜質(zhì)L
|
721401-53-2
|
|
SulfaMethoxazole Related CoMpound F
|
磺胺甲噁唑雜質(zhì)F
|
17103-52-5
|
|
Finerenone
|
非奈利酮
|
1050477-31-0
|
|
|
注射用頭孢他啶雜質(zhì)B
|
97148-38-4
|
|
|
二十二碳六烯酸甲酯
|
301-01-9
|
|
Doxapram EP Impurity A
|
多沙普侖EP雜質(zhì)A
|
3192-64-1
|
|
|
|
1262340-21-5
|
|
|
雜質(zhì)24 5-氯-2-(2-甲基-2H-四唑-5-基)吡啶
|
2095840-88-1
|
|
N-(4-AMinobenzenesulfonyl) SulfaMethoxazole
|
磺胺甲噁唑雜質(zhì)B
|
135529-16-7
|
|
|
N,N'-二[4-氯-3-(三氟甲基)苯基]脲
|
370-50-3
|
|
Levosimendan Impurity 10
|
左西孟旦雜質(zhì)C
|
134678-47-0
|
|
|
|
1556190-62-5
|
|
Finerenone Impurity 22
|
非奈利酮雜質(zhì)
|
2640280-85-7
|
|
|
美洛昔康雜質(zhì)
|
632-25-7
|
|
4-Amino-6-chlorobenzene-1,3-disulfonamide
|
氫氯噻嗪雜質(zhì)A
|
121-30-2
|
|
(S)-(((1-(6-aMino-9H-purin-9-yl)propan-2-yloxy)Methyl)phosphoryl)bis(oxy)bis(Methylene) isopropyl dicarbonate fuMarate
|
富馬酸替諾福韋二吡呋酯異構(gòu)體
|
1432630-26-6
|
|
|
枸櫞酸托法替布雜質(zhì)HC1309-326
|
1640972-35-5
|
|
Loxoprofen Impurity E
|
洛索洛芬鈉雜質(zhì)E
|
1091621-62-3
|
|
Palmitic acid
|
軟脂酸
|
57-10-3
|
|
|
哈西奈德雜質(zhì)16
|
2367-73-9
|
|
Rosuvastatin calcium
|
瑞舒伐他汀鈣
|
147098-20-2
|
|
|
哈西奈德雜質(zhì)14
|
1524-86-3
|
|
|
3-氨基鄰苯二甲酸-1-甲酯
|
103259-06-9
|
|
ETHYL-(3,4-DIMETHOXY-PHENYL)-AMINE
|
|
32953-13-2
|
|
|
柔紅霉素EP雜質(zhì)E
|
|
|
|
普萘洛爾雜質(zhì)25
|
2111-24-2
|
|
3-amino-4-hydroxy-5-nitrobenzoic acid
|
布美他尼5-d
|
267014-44-8
|
|
LXI-15028-02
|
|
1640981-20-9
|
|
3,5-DINITRO-4-HYDROXYBENZOIC ACID
|
布美他尼2-b
|
41430-25-5
|
|
1,2-Dinitroglycerin
|
硝化甘油溶液EP雜質(zhì)D
|
621-65-8
|
|
|
雜質(zhì)22 6-(2-甲基-2H-四唑-5-基)吡啶-3-胺
|
1552277-18-5
|
|
|
N、N，N'，N'-四丁基丙烷-1,3-二胺
|
94107-99-0
|
|
|
6-磷酸甲基加合物PMPA
|
1425688-72-7
|
|
|
雜質(zhì)Z
|
144841-10-1
|
|
4-(4-cyano-2-methoxyphenyl)-5-methoxy-2,8-dimethyl-1,4-dihydro- 1,6-naphthyridine-3-carboxamide
|
非奈利酮雜質(zhì)
|
2640280-84-6
|
|
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxamide
|
外消旋酰胺基萘啶
|
2084136-51-4
|
|
|
普萘洛爾雜質(zhì)11
|
5234-06-0
|
|
(1R,2S,3R)-Aprepitant
|
阿瑞匹坦RSR雜質(zhì)
|
1185502-97-9
|
|
|
鹽酸曲唑酮雜質(zhì)4
|
1781591-94-3
|
|
|
美洛昔康雜質(zhì)
|
82514-69-0
|
|
Levocarnitine Impurity A
|
左卡尼汀雜質(zhì)A順式異構(gòu)體
|
835638-57-8
|
|
|
LXI-15028對映異構(gòu)體
|
942195-56-4
|
|
Trazodone Impurity E
|
鹽酸曲唑酮雜質(zhì)E
|
1346599-35-6
|
|
3,5-diamino-4-phenoxybenzoic acid
|
布美他尼3-a
|
688318-18-5
|
|
N-succinylglycine
|
吡拉西坦雜質(zhì)E
|
5626-41-5
|
|
Bumetanide Impurity 4
|
布美他尼雜質(zhì)4
|
56106-56-0
|
|
|
N-(3-氯丁基)二丁基胺
|
1250316-60-9
|
|
|
3-氯-4-氟苯胺取代基位置異構(gòu)體
|
936558-43-9
|
|
|
鹽酸異丙腎上腺素雜質(zhì)A
|
5178-52-9
|
|
N,N-diethyl-2,2-difluoroacetamide
|
N，N- 二乙基-2,2-二氟乙酰胺
|
686-11-3
|
|
Trimethoprim EP Impurity A
|
甲氧芐啶雜質(zhì)A
|
213745-86-9
|